NATCO Pharma Limited

NATCOPHARM.NS·NSE·Healthcare
Compare
784.45−16.40 (−2.05%)today
At close: Oct 21, 3:29 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close800.85
Open799.00
Day range780.00800.65
52-week range779.001,226.80
Off day high−2.02%
Off 52-week high−36.06%
Volume480.02K
Avg. volume (3M)433.25K
Market cap144.34B
EPS (TTM)63.37
Forward P/E16.56
P/E ratio (TTM)12.38
Dividend yield0.74% (5.95)
Beta (5Y)0.15
Shares outstanding184.00M
Short interest—
Earnings dateAug 14, 2026
Analyst target1,004.44
Profit margin32.84%

Against its peers

Compare in full ›
NATCOPHARM.NS IPCALAB.BO GRANULES.BO AKUMS.BO TAK 1795.TW
Market cap 144.34B 486.30B 194.90B 106.04B 64.15B 46.89B
P/E (TTM) 12.4 37.1 35.7 36.4 — 12.4
Forward P/E 16.6 27.2 26.8 20.3 37.9 7.4
Price/book 1.5 6.0 4.9 3.2 1.3 2.0
Dividend yield 0.74% 0.33% 0.26% 0.14% 3.07% 1.47%
1-year change −4.89% +42.82% +0.63% +51.93% +42.01% −39.08%
Today −2.05% +5.60% −0.43% −2.40% +2.40% +0.57%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.

BusinessLine·

Natco Pharma launches generic cancer drug Carboplatin in US

Drug maker Natco Pharma on Monday announced the launch of Carboplatin Injection in the US market through its subsidiary Natco Pharma USA LLC. The product, a generic version of Paraplatin, has been launched in manufacturing collaboration…

From articles in the 4Search news index.

In the news

11mentions in 30 days
11with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.